Brief: ABVC BioPharma Announces Completion of Phase II Part 2 Clinical Study Site Initiation Visit at UCSF
26/04/2023 14:28
April 26 (Reuters) - ABVC Biopharma Inc ABVC.O :
* ABVC BIOPHARMA ANNOUNCES COMPLETION OF PHASE II PART 2
CLINICAL
STUDY SITE INITIATION VISIT AT UCSF
Source text for Eikon: ID:nGNX4NgjJL
Further company coverage: ABVC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21
NASDAQ RESUMED AT 09:05 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:43 PM
Brief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon